Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

NICE recommends BMS and Pfizer’s Eliquis for blood clots

Will be a treatment option for venous thromboembolism

- PMLiVE

Merck and Eisai link up on anti-PD-1 combinations

Will test Keytruda with both Lenvima and Halaven 

- PMLiVE

PharmaVentures adds to business development team

Graham Combe has over 18 years of experience

- PMLiVE

Eurocom Healthcare Comms expands to Turkey

Ixir Healthcare Communications joins alliance

Bristol-Myers Squibb (BMS) building

Opdivo gains new US lung cancer licence

Adds to Bristol-Myers Squibb’s therapeutic vaccine’s melanoma indication

- PMLiVE

Digital health charge led by millennials in the US

But older patients more likely to use pharma sites if directed by a doctor

Build your e-detailing argumentation

We’ve written a number of posts recently giving insights into the Anthill method for structuring e-detailing & CLM presentations. To help you overview, we’ve put these argumentation posts together.

Anthill Agency

- PMLiVE

Adaptimmune appoints former GSK executives

Dr Rafael Amado and Adrian Rawcliffe join the biotech’s top ranks

- PMLiVE

Campaigns improve cancer symptom awareness, claims BJC

Has shown an increase in GP visits for possible cancer symptoms

- PMLiVE

AbbVie to acquire cancer biopharma Pharmacyclics for $21bn

Comes six months after the US firm pulled out of a $54bn deal with Shire

- PMLiVE

Nikon expands into healthcare and buys retinal tech firm

Japanese camera and technology company spends big on Scotland’s Optos

- PMLiVE

SEC calls for greater disclosure from pharma

Claims companies are leaving themselves open to enforcement action

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links